The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers
Clinical & Manufacturing

BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers

DEC 10, 2018
Lallemand Health Solutions Invests to Double Probiotic Production Capacity.
Biotics and Supplements

Lallemand Health Solutions Invests to Double Probiotic Production Capacity.

DEC 10, 2018
Danone North America Announces 2018-2019 Gut Microbiome, Yogurt and Probiotics Fellowship Grant
Biotics and Supplements

Danone North America Announces 2018-2019 Gut Microbiome, Yogurt and Probiotics Fellowship Grant

DEC 9, 2018
MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients
Clinical & Manufacturing

MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients

DEC 3, 2018
Changed Microbiome After Caesarean Birth Impacts Baby’s Immune System, Research by LCSB Finds
Pharma & Human Health

Changed Microbiome After Caesarean Birth Impacts Baby’s Immune System, Research by LCSB Finds

DEC 1, 2018
Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD
Clinical & Manufacturing

Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD

NOV 27, 2018
New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc.
Gut-Brain Axis

New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc.

NOV 23, 2018
Pharmabiotics Young Investigator Awards: Supporting Tomorrow’s Microbiome Opinion Leaders
Editor's Choice

Pharmabiotics Young Investigator Awards: Supporting Tomorrow’s Microbiome Opinion Leaders

NOV 22, 2018
Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
Clinical & Manufacturing

Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development

NOV 22, 2018
Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing
Pharma & Human Health

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

NOV 21, 2018
6th Microbiome R&D and Business Collaboration Forum USA Summary
Editor's Choice

6th Microbiome R&D and Business Collaboration Forum USA Summary

NOV 20, 2018